Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Equity (2018 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Return on Equity readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q1 2026 for Kiniksa Pharmaceuticals International, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q3 2022 to a low of 0.01% in Q1 2022.
  • Median Return on Equity over the past 5 years was 0.0% (2025), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Equity: rose 1bps in 2022 and later decreased -1bps in 2023.
  • Kiniksa Pharmaceuticals International's Return on Equity stood at 0.0% in 2022, then plummeted by -199bps to 0.0% in 2023, then soared by 64bps to 0.0% in 2024, then surged by 232bps to 0.0% in 2025, then grew by 16bps to 0.0% in 2026.
  • The last three reported values for Return on Equity were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.